BARTALENA, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 2.107
AS - Asia 1.093
EU - Europa 794
SA - Sud America 201
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.297
Nazione #
US - Stati Uniti d'America 2.034
SG - Singapore 361
CN - Cina 265
SE - Svezia 215
HK - Hong Kong 206
BR - Brasile 157
IT - Italia 144
DE - Germania 143
VN - Vietnam 115
FR - Francia 55
BG - Bulgaria 48
GB - Regno Unito 46
CA - Canada 45
CI - Costa d'Avorio 44
RU - Federazione Russa 38
FI - Finlandia 37
IN - India 34
TR - Turchia 34
SN - Senegal 22
AR - Argentina 14
ZA - Sudafrica 14
AT - Austria 13
JP - Giappone 13
BD - Bangladesh 12
MX - Messico 10
UA - Ucraina 10
BE - Belgio 9
CO - Colombia 7
IQ - Iraq 7
JM - Giamaica 7
ES - Italia 6
CL - Cile 5
CZ - Repubblica Ceca 5
NP - Nepal 5
PH - Filippine 5
PK - Pakistan 5
RO - Romania 5
UY - Uruguay 5
UZ - Uzbekistan 5
CH - Svizzera 4
NL - Olanda 4
PL - Polonia 4
PY - Paraguay 4
EC - Ecuador 3
ET - Etiopia 3
IE - Irlanda 3
KE - Kenya 3
KR - Corea 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
IR - Iran 2
OM - Oman 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
DZ - Algeria 1
EU - Europa 1
GT - Guatemala 1
GU - Guam 1
ID - Indonesia 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UG - Uganda 1
VI - Stati Uniti Isole Vergini 1
YE - Yemen 1
Totale 4.297
Città #
Ashburn 241
Hong Kong 202
Singapore 189
Woodbridge 174
Chandler 172
Santa Clara 156
Dallas 138
San Jose 128
Fairfield 116
Houston 102
Ann Arbor 74
Shanghai 73
New York 62
Munich 49
Sofia 48
Beijing 46
Wilmington 46
Abidjan 44
Cambridge 44
Seattle 42
Boardman 40
Ottawa 38
Los Angeles 34
Florence 32
Frankfurt am Main 32
Ho Chi Minh City 31
Serra 27
Lawrence 24
Princeton 24
Dakar 22
Hanoi 22
Lauterbourg 22
Dearborn 21
Medford 20
Turku 19
Istanbul 17
London 16
Pisa 15
Buffalo 14
Bremen 13
Des Moines 12
Izmir 12
Marseille 12
Düsseldorf 11
Lancaster 11
Redondo Beach 11
Tokyo 11
Denver 10
Vienna 10
Da Nang 8
Guangzhou 8
Ogden 8
Orem 8
Brooklyn 7
Changsha 7
Haiphong 7
San Diego 7
Chennai 6
Curitiba 6
Falkenstein 6
Johannesburg 6
Kunming 6
Belo Horizonte 5
Brussels 5
Cascina 5
Hebei 5
Helsinki 5
Jacksonville 5
Jüchen 5
Manchester 5
Milan 5
Montevideo 5
Nuremberg 5
Quanzhou 5
São Paulo 5
Tashkent 5
Atlanta 4
Boston 4
Brasília 4
Chicago 4
Dong Ket 4
Fuzhou 4
Kingston 4
Mexico City 4
Nanchang 4
Nanjing 4
Rome 4
Xiamen 4
Augusta 3
Biên Hòa 3
Dhaka 3
Goiânia 3
Hyderabad 3
Jiaxing 3
Jinan 3
Kilburn 3
Livorno 3
Louisville 3
Memphis 3
Miami 3
Totale 2.973
Nome #
REGULATION OF CARDIAC FATTY ACID METABOLISM IN TRANSGENIC MICE OVEREXPRESSING BOVINE GROWTH HORMONE 238
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 212
TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves’ disease 189
Use of solubilized radioiodinated thyroid plasma membranes for purification of TSH-receptor by affinity chromatography 179
LACK OF NOCTURNAL SERUM THYROTROPIN (TSH) SURGE IN PATIENTS WITH CHRONIC-RENAL-FAILURE UNDERGOING REGULAR MAINTENANCE HEMOFILTRATION - A CASE OF CENTRAL HYPOTHYROIDISM 175
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 170
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? 168
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 167
Interference of thyroglobulin in TSAb detection by radio-receptor assay 162
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves 162
Iodine and thyroid dysfunction in uremia 162
GH secretion is impaired in patients with primary hyperparathyroidism 161
Selenium in the Treatment of Thyroid Diseases 161
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 153
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy 149
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 148
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy 116
2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction 111
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic 108
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 107
Thyroid autoimmunity and endemic goiter 104
Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: A 2015 Italian Society of Endocrinology Consensus Statement 98
Real-life data on the impact of medical therapy for amiodarone-induced thyrotoxicosis on CV events and hospitalizations 94
Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH 92
Measurement of thyroid cell surface antibodies by radioassay using human cultured thyroid cells 90
Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity 88
Graves’ disease and Turner’s syndrome 86
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 85
Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis 74
Orbital Cobalt Radiotherapy and Systemic or Retrobulbar Corticosteroids for Graves’ Ophthalmopathy 71
Studies on thyroid cell surface antigens using cultured human thyroid cells 65
null 62
Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct 60
Teprotumumab for Graves??? orbitopathy and ototoxicity: moving problems from eyes to ears? 49
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 48
Totale 4.364
Categoria #
all - tutte 14.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022324 8 10 7 30 51 36 8 11 27 37 32 67
2022/2023567 70 89 32 47 51 54 7 42 134 2 31 8
2023/2024225 10 18 27 12 26 56 23 8 3 6 11 25
2024/20251.075 5 35 7 62 105 124 87 53 113 115 149 220
2025/20261.263 118 142 191 117 139 94 191 66 44 100 43 18
2026/20276 6 0 0 0 0 0 0 0 0 0 0 0
Totale 4.364